by J.K. Wong, H. Bergman, M. Muthuraman, S. Groppa, S.A. Sheth, H.M. Bronte-Stewart, K.B. Wilkins, M.N. Petrucci, E. Lambert, Y. Kehnemouyi, P. Starr, S. Little, J. Anso, R. Gilron, L. Poree, G.P. Kalamangalam, G. Worrell, K.J. Miller, N.D. Schiff, C.R. Butson, J. Henderson, J.W. Judy, A. Ramirez-Zamora, K.D. Foote, G. Deuschl, R. Wolke, P.A. Silburn, L. Li, G. Oyama, H. Kamo, S. Sekimoto, N. Hattori, J.J. Giordano, D. DiEuliis, J. Shook, D.D. Dougherty, A.S. Widge, H.S. Mayberg, J. Cha, K.S. Choi, S. Heisig, M. Obatusin, E. Opri, S.B. Kaufman, P Shirvalkar, C.J. Rozell, S. Alagapan, R.S. Raike, H. Bokil, D. Greene and M.S. Okun
Abstract:
DBS Think Tank IX was held on August 25-27, 2021 in Orlando FL with US based participants largely in person and overseas participants joining by video conferencing technology. The DBS Think Tank was founded in 2012 and provides an open platform where clinicians, engineers and researchers (from industry and academia) can freely discuss current and emerging deep brain stimulation (DBS) technologies as well as the logistical and ethical issues facing the field. The consensus among the DBS Think Tank IX speakers was that DBS expanded in its scope and has been applied to multiple brain disorders in an effort to modulate neural circuitry. After collectively sharing our experiences, it was estimated that globally more than 230,000 DBS devices have been implanted for neurological and neuropsychiatric disorders. As such, this year’s meeting was focused on advances in the following areas: neuromodulation in Europe, Asia and Australia; cutting-edge technologies, neuroethics, interventional psychiatry, adaptive DBS, neuromodulation for pain, network neuromodulation for epilepsy and neuromodulation for traumatic brain injury.
Reference:
Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy and Traumatic Brain InjuryJ.K. Wong, H. Bergman, M. Muthuraman, S. Groppa, S.A. Sheth, H.M. Bronte-Stewart, K.B. Wilkins, M.N. Petrucci, E. Lambert, Y. Kehnemouyi, P. Starr, S. Little, J. Anso, R. Gilron, L. Poree, G.P. Kalamangalam, G. Worrell, K.J. Miller, N.D. Schiff, C.R. Butson, J. Henderson, J.W. Judy, A. Ramirez-Zamora, K.D. Foote, G. Deuschl, R. Wolke, P.A. Silburn, L. Li, G. Oyama, H. Kamo, S. Sekimoto, N. Hattori, J.J. Giordano, D. DiEuliis, J. Shook, D.D. Dougherty, A.S. Widge, H.S. Mayberg, J. Cha, K.S. Choi, S. Heisig, M. Obatusin, E. Opri, S.B. Kaufman, P Shirvalkar, C.J. Rozell, S. Alagapan, R.S. Raike, H. Bokil, D. Greene and M.S. Okun. Frontiers in Human Neuroscience, vol. 16, March 2022.
Bibtex Entry:
@article{wong.22,
author = {Wong, J.K. and Bergman, H. and Muthuraman, M. and Groppa, S. and Sheth, S.A. and Bronte-Stewart, H.M. and Wilkins, K.B. and Petrucci, M.N. and Lambert, E. and Kehnemouyi, Y. and Starr, P. and Little, S. and Anso, J. and Gilron, R. and Poree, L. and Kalamangalam, G.P. and Worrell, G. and Miller, K.J. and Schiff, N.D. and Butson, C.R. and Henderson, J. and Judy, J.W. and Ramirez-Zamora, A. and Foote, K.D. and Deuschl, G. and Wolke, R. and Silburn, P.A. and Li, L. and Oyama, G. and Kamo, H. and Sekimoto, S. and Hattori, N. and Giordano, J.J. and DiEuliis, D. and Shook, J. and Dougherty, D.D. and Widge, A.S. and Mayberg, H.S. and Cha, J. and Choi, K.S. and Heisig, S. and Obatusin, M. and Opri, E. and Kaufman, S.B. and Shirvalkar, P and Rozell, C.J. and Alagapan, S. and Raike, R.S. and Bokil, H. and Greene, D. and Okun, M.S.},
title = {Proceedings of the {N}inth {A}nnual {D}eep {B}rain {S}timulation {T}hink {T}ank: {A}dvances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy and Traumatic Brain Injury},
year = 2022,
month = mar,
volume = {16},
journal = {Frontiers in Human Neuroscience},
URL={https://www.frontiersin.org/articles/10.3389/fnhum.2022.813387},
abstract = {DBS Think Tank IX was held on August 25-27, 2021 in Orlando FL with US based participants largely in person and overseas
participants joining by video conferencing technology. The DBS Think Tank was founded in 2012 and provides an open platform
where clinicians, engineers and researchers (from industry and academia) can freely discuss current and emerging deep brain
stimulation (DBS) technologies as well as the logistical and ethical issues facing the field. The consensus among the DBS Think Tank IX
speakers was that DBS expanded in its scope and has been applied to multiple brain disorders in an effort to modulate neural
circuitry. After collectively sharing our experiences, it was estimated that globally more than 230,000 DBS devices have been
implanted for neurological and neuropsychiatric disorders. As such, this year’s meeting was focused on advances in the following
areas: neuromodulation in Europe, Asia and Australia; cutting-edge technologies, neuroethics, interventional psychiatry, adaptive
DBS, neuromodulation for pain, network neuromodulation for epilepsy and neuromodulation for traumatic brain injury.}
}